Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 1 January 2026
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 1 January 2026. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
In response to a DSE query letter to the company regarding a news published in the website/online news portal titled "Trading of Beximco Pharma is being suspended on the London Stock Exchange" (translated from Bengali to English) on December 26, 2025, the company has informed DSE, among others, the following: "?1. Pursuant to Rule 19 of the AIM Rules for Companies, an AIM-listed issuer is required to publish its Annual Report and Accounts within six months of the end of its financial year. (cont.1)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6955f4c4b322cf5e5192a248
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.